PTEN suppression activates the AKT/NF-κB-p65 pathway, increasing chemokine (C-C motif) ligand 2 (CCL2) expression and attracting MDSCs, ultimately promoting lung metastasis in BC (50). This evidence concerns the gene CCL2 and breast cancer.